PD model mice were also used to identify glial lipocalin-2 (Lcn-2) as a protein contributing to the disease pathogenesis since its levels were increased in the SN and striatum of the MPTP-treated animals (Kim B. W. et al., 2016). Here, LCN2 is linked to Parkinson disease.